购物车
全部删除
您的购物车当前为空
hCA-I/hCA-II-IN-1 (Compound P4) 是一种高效的双重抑制剂,针对人碳酸酐酶 I (hCA-I) 和人碳酸酐酶 II (hCA-II) 的Ki值分别为0.22 μM和0.33 μM。hCA-I/hCA-II-IN-1 可用于研究与CA酶有关的疾病,如青光眼、高血压和溃疡。
hCA-I/hCA-II-IN-1 (Compound P4) 是一种高效的双重抑制剂,针对人碳酸酐酶 I (hCA-I) 和人碳酸酐酶 II (hCA-II) 的Ki值分别为0.22 μM和0.33 μM。hCA-I/hCA-II-IN-1 可用于研究与CA酶有关的疾病,如青光眼、高血压和溃疡。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
hCA-I/hCA-II-IN-1 相关产品
| 产品描述 | hCA-I/hCA-II-IN-1 (Compound P4) is a potent dual inhibitor of human carbonic anhydrase I (hCA-I) and human carbonic anhydrase II (hCA-II), with Ki values of 0.22 μM and 0.33 μM respectively. hCA-I/hCA-II-IN-1 is useful for research into diseases related to CA enzymes, including glaucoma, hypertension, and ulcers. |
| 靶点活性 | CA I (human):0.22 μM (Ki) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容